Table 1. Serum Levels of Opsonins and... | American Society of Hematology

Table 1.

Serum Levels of Opsonins and Acute-Phase Reactants After In Vivo Treatment With rhIFN-γ

	0 h	24 h	48 h	72 h	168 h
LBP (mg/mL, n = 12)	17.8 ± 8.2	24.8 ± 7.7^*	23.8 ± 9.7	19.6 ± 6.5	16.2 ± 5.2
Neopterin (ng/mL, n = 15)	2.1 ± 0.5	4.7 ± 0.9^†	6.6 ± 1.4^†	5.4 ± 1.1^†	2.1 ± 0.4
β₂-m (ng/mL, n = 15)	33.5 ± 4.7	49.0 ± 9.7^†	58.1 ± 10.7^†	50.5 ± 11.3^†	33.0 ± 7.0
sCD14 (mg/mL, n = 12)	0.96 ± 0.18	1.00 ± 0.18	1.02 ± 0.15	1.07 ± 0.3	0.94 ± 0.18
sICAM (ng/mL, n = 15)	16.8 ± 3.7	18.7 ± 3.3	20.8 ± 5.8	19.8 ± 3.2	18.3 ± 4.3
C3 (mg/dL, n = 12)	107 ± 24	ND	121 ± 30	ND	111 ± 18
C4 (mg/dL, n = 12)	28 ± 8	ND	31 ± 6	ND	29 ± 5
CRP (mg/dL, n = 10)	0.5 ± 0.2	ND	1.1 ± 1.4	ND	0.4 ± 0.1
IgG (mg/dL, n = 7)	990 ± 189	ND	991 ± 246	ND	996 ± 218
IgM (mg/dL, n = 7)	108 ± 26	ND	106 ± 25	ND	117 ± 31

	0 h	24 h	48 h	72 h	168 h
LBP (mg/mL, n = 12)	17.8 ± 8.2	24.8 ± 7.7^*	23.8 ± 9.7	19.6 ± 6.5	16.2 ± 5.2
Neopterin (ng/mL, n = 15)	2.1 ± 0.5	4.7 ± 0.9^†	6.6 ± 1.4^†	5.4 ± 1.1^†	2.1 ± 0.4
β₂-m (ng/mL, n = 15)	33.5 ± 4.7	49.0 ± 9.7^†	58.1 ± 10.7^†	50.5 ± 11.3^†	33.0 ± 7.0
sCD14 (mg/mL, n = 12)	0.96 ± 0.18	1.00 ± 0.18	1.02 ± 0.15	1.07 ± 0.3	0.94 ± 0.18
sICAM (ng/mL, n = 15)	16.8 ± 3.7	18.7 ± 3.3	20.8 ± 5.8	19.8 ± 3.2	18.3 ± 4.3
C3 (mg/dL, n = 12)	107 ± 24	ND	121 ± 30	ND	111 ± 18
C4 (mg/dL, n = 12)	28 ± 8	ND	31 ± 6	ND	29 ± 5
CRP (mg/dL, n = 10)	0.5 ± 0.2	ND	1.1 ± 1.4	ND	0.4 ± 0.1
IgG (mg/dL, n = 7)	990 ± 189	ND	991 ± 246	ND	996 ± 218
IgM (mg/dL, n = 7)	108 ± 26	ND	106 ± 25	ND	117 ± 31

All results are expressed as the mean ± SD.

Abbreviation: ND, not done.

P < .05 when compared with pretreatment levels.

P < .0001 when compared with pretreatment levels.